MT1E and prostate carcinoma: They identified 455 differentially expressed genes through global gene expression profiling, among which seven genes (CHI3L2, FABP7, GHRH, GPR52, MT1E, OLR1, and SAA2) were selected for further validation in two independent prostate cancer cohorts.